AbbVie's Venclexta Misses Goal in Myelodysplastic Syndromes Study

• click to rate

  Posted by Two Blokes Jun 17 - Filed in Stock - 3 views
  
  Venclexta fails to meet survival goals in ABBV's phase III MDS study, marking another clinical setback for the cancer drug.